POS AM Filing

GUIDED THERAPEUTICS INC CIK: 924515

Filing Information

Form Type	POS AM
Accession Number	`0001121781-13-000081`
Period End Date	20121231
Filing Date	20130405
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	gthp-20121231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 65 Income Statement 34 Cash Flow Statement 64 Stockholders Equity 18

Balance Sheet 65 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$12.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$20.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.27M	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$52.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$64.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $12 and $20 at December 31, 2012 and December 31, 2011	`AccountsReceivableNet`	$117.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $12 and $20 at December 31, 2012 and December 31, 2011	`AccountsReceivableNet`	$107.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory, net of reserves of $ 52 and $64 at December 31, 2012 and 2011, respectively	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$520.00K	USD	Point-in-time
Inventory, net of reserves of $ 52 and $64 at December 31, 2012 and 2011, respectively	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$524.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$54.00K	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	100,000.00	shares	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145,000.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$198.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.89M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	62,282.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.87M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	52,211.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.03M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.27M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	52,211.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	62,282.00	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$331.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$386.00K	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.42M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.60M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$4.31M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.48M	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$30.00K	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$79.00K	USD	Point-in-time
Current portion of long-term debt	`ShortTermBorrowings`	$25.00K	USD	Point-in-time
Current portion of long-term debt	`ShortTermBorrowings`	$4.00K	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	$362.00K	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	$419.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.10M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$765.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$757.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.04M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$453.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$40.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.73M	USD	Point-in-time
Long-term loan payable, less current portion	`LongtermDebtPayableLessCurrentPortion`	-	USD	Point-in-time
Long-term loan payable, less current portion	`LongtermDebtPayableLessCurrentPortion`	$4.00K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$2.73M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$2.35M	USD	Point-in-time
Common stock, $.001 par value; 145,000 and 100,000 shares authorized, 62,282 and 52,211 shares issued and outstanding as of December 31, 2012 and 2011, respectively	`CommonStockValue`	$62.00K	USD	Point-in-time
Common stock, $.001 par value; 145,000 and 100,000 shares authorized, 62,282 and 52,211 shares issued and outstanding as of December 31, 2012 and 2011, respectively	`CommonStockValue`	$52.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.61M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$93.27M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$104.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$104.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-85.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-92.10M	USD	Point-in-time
TOTAL GUIDED THERAPEUTICS STOCKHOLDERS' EQUITY	`TotalGuidedTherapeuticsStockholdersEquity`	$1.47M	USD	Point-in-time
TOTAL GUIDED THERAPEUTICS STOCKHOLDERS' EQUITY	`TotalGuidedTherapeuticsStockholdersEquity`	$1.13M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$104.00K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	-	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.58M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.13M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.48M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$4.31M	USD	Point-in-time

Income Statement 34 line items

Line Item	Tag	Value	Unit	Period
Contract and grant revenue	`Revenues`	$3.34M	USD	Annual
Contract and grant revenue	`Revenues`	$3.60M	USD	Annual
Sales - devices and disposables	`SalesDevicesAndDisposables`	$25.00K	USD	Annual
Sales - devices and disposables	`SalesDevicesAndDisposables`	$72.00K	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$117.00K	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$106.00K	USD	Annual
Gross Loss	`GrossProfit`	$-81.00K	USD	Annual
Gross Loss	`GrossProfit`	$-45.00K	USD	Annual
Claim settlement	`ClaimSettlement`	$3.62M	USD	Annual
Claim settlement	`ClaimSettlement`	-	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.78M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.23M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$424.00K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$287.00K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.92M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.58M	USD	Annual
Total operating expenses	`OperatingExpenses`	$7.57M	USD	Annual
Total operating expenses	`OperatingExpenses`	$10.27M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-4.28M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-6.76M	USD	Annual
OTHER INCOME	`OtherIncome`	-	USD	Annual
OTHER INCOME	`OtherIncome`	$192.00K	USD	Annual
INTEREST EXPENSE	`InterestExpense`	$80.00K	USD	Annual
INTEREST EXPENSE	`InterestExpense`	$72.00K	USD	Annual
LOSS FROM OPERATIONS	`LossBeforeIncomeTaxes`	$4.35M	USD	Annual
LOSS FROM OPERATIONS	`LossBeforeIncomeTaxes`	$6.64M	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
NET LOSS	`NetIncomeLoss`	$-4.35M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-6.64M	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE	`EarningsPerShareBasicAndDiluted`	$-0.14	USD	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	48,868.00	shares	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	57,429.00	shares	Annual

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-4.35M	USD	Annual
Net loss	`NetIncomeLoss`	$-6.64M	USD	Annual
Bad debt (recovery) expense	`BadDebtRecovery`	$18.00K	USD	Annual
Bad debt (recovery) expense	`BadDebtRecovery`	$-3.00K	USD	Annual
Depreciation	`DepreciationAndAmortization`	$34.00K	USD	Annual
Depreciation	`DepreciationAndAmortization`	$361.00K	USD	Annual
Issuance of warrants in connection with settlement of claim	`IssuanceOfWarrantsInConnectionWithSettlementOfClaim`	-	USD	Annual
Issuance of warrants in connection with settlement of claim	`IssuanceOfWarrantsInConnectionWithSettlementOfClaim`	$3.62M	USD	Annual
Stock based compensation	`ShareBasedCompensation`	$645.00K	USD	Annual
Stock based compensation	`ShareBasedCompensation`	$870.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$13.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-50.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-520.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-4.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-144.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-24.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$55.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-180.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-337.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$187.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-413.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$121.00K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-168.00K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$513.00K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$299.00K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$3.91M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-3.67M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-2.73M	USD	Annual
Additions to capitalized software costs	`CapitalizedComputerSoftwareAdditions`	$-260.00K	USD	Annual
Additions to capitalized software costs	`CapitalizedComputerSoftwareAdditions`	$640.00K	USD	60 Qtrs
Additions to capitalized software costs	`CapitalizedComputerSoftwareAdditions`	-	USD	Annual
Additions to fixed assets	`AdditionsToNoncurrentAssets`	$-552.00K	USD	Annual
Additions to fixed assets	`AdditionsToNoncurrentAssets`	$-444.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-704.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-552.00K	USD	Annual
Proceeds from debt financing	`ProceedsFromIssuanceOfDebt`	-	USD	Annual
Proceeds from debt financing	`ProceedsFromIssuanceOfDebt`	$86.00K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.77M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Payments made on notes payables	`PaymentsOfLoanCosts`	$125.00K	USD	Annual
Payments made on notes payables	`PaymentsOfLoanCosts`	$215.00K	USD	Annual
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$818.00K	USD	Annual
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$3.10M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.37M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.06M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.16M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.07M	USD	Annual
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$3.27M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`Cash`	$2.20M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`Cash`	$1.04M	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$48.00K	USD	Annual
Cash paid for Interest	`InterestPaid`	$183.00K	USD	Annual
Acquisition of minority interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$104.00K	USD	Annual
Acquisition of minority interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	Annual
Conversion of accrued expenses into common stock	`ConversionOfAccruedExpensesIntoCommonStock`	$27.00K	USD	Annual
Conversion of accrued expenses into common stock	`ConversionOfAccruedExpensesIntoCommonStock`	$162.00K	USD	Annual
Purchase of fixed assets by issuing notes payable	`PurchaseOfFixedAssetsByIssuingNotesPayable`	$50.00K	USD	Annual
Purchase of fixed assets by issuing notes payable	`PurchaseOfFixedAssetsByIssuingNotesPayable`	-	USD	Annual
Conversion of interest to principal	`ConversionOfInterestToPrincipal`	$63.00K	USD	Annual
Conversion of interest to principal	`ConversionOfInterestToPrincipal`	-	USD	Annual
Deemed dividends in the form of warrants to purchase common stock.	`DeemedDividendsInFormOfWarrantsToPurchaseCommonStock.`	-	USD	Annual
Deemed dividends in the form of warrants to purchase common stock.	`DeemedDividendsInFormOfWarrantsToPurchaseCommonStock.`	$2.66M	USD	Annual

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$1.13M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$1.01M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$1.58M	USD	Point-in-time
Issuance of common stock, Amount	`IssuanceOfCommonStockAmount`	$1.77M	USD	Annual
Exercise of warrants/options, Amount	`ExerciseOfWarrantsoptionsAmount`	$818.00K	USD	Annual
Exercise of warrants/options, Amount	`ExerciseOfWarrantsoptionsAmount`	$3.10M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$645.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$870.00K	USD	Annual
Issuance of warrants for claim settlement	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$3.62M	USD	Annual
Conversion of debts into common stock, Amount	`ConversionOfDebtsIntoCommonStockAmount`	$27.00K	USD	Annual
Issuance of stock, Amount	`StockIssuedDuringPeriodValueIssuedForCash`	$162.00K	USD	Annual
Deemed dividends	`DeemedDividends`	-	USD	Annual
Acquisition of minority interest	`AdjustmentToAdditionalPaidInCapitalAcquistionOfMinorityInterest`	-	USD	Annual
Net Loss	`NetIncomeLoss`	$-4.35M	USD	Annual
Net Loss	`NetIncomeLoss`	$-6.64M	USD	Annual
Ending Balance, Amount	`StockholdersEquity`	$1.13M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$1.01M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$1.58M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.